Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer

Abroad (travel likely)Recruiting

Conditions

Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Taiwan University Hospital, Taipei, Taiwan
Contact: Study coordinator (Hsing-Chen Tsai, M.D., Ph.D) · htsai@ntu.edu.tw · +886-2-23123456

Study leads

Hsing-Chen Tsai, M.D., Ph.D
Study Chair
Graduate institute of Toxicology, NTUCM; Department of Internal Medicine, NTUH

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer Stage IV · Non-small Cell Lung Cancer Recurrent

Abroad (travel likely)RecruitingPHASE1, PHASE2

St Louis, United States

Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.

Lung Cancer

Abroad (travel likely)Recruiting

Shanghai, China · Shanghai, China

EXoPERT EMERALD Clinical Study

Breast Cancer · Colon Cancer · Pancreatic Cancer

Abroad (travel likely)Recruiting

Long Beach, United States · Los Angeles, United States

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Unresectable Melanoma · Metastatic Melanoma · Stage III Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Miami, United States